In this review, we summarize current significant achievements applied in treatment of TNBC with molecular targeted therapy, immunotherapy, and antibody-drug conjugates and upcoming drugs for triple negative breast cancer will be summarized. Key words: triple-negative breast cancer (TNBC), breast cancer, estrogen